Literature DB >> 17675531

Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.

S E Heron, K Cox, B E Grinton, S M Zuberi, S Kivity, Z Afawi, R Straussberg, S F Berkovic, I E Scheffer, J C Mulley.   

Abstract

BACKGROUND: Benign familial neonatal seizures are most often caused by mutations in the voltage-gated potassium channel subunit gene KCNQ2. More than 60 mutations have been described in BFNS families, approximately half of which lead to protein truncation. The hypothesis of this study was that deletion or duplication of >or=1 exons of KCNQ2 could cause BFNS in cases without coding or splicing mutations.
METHODS: Multiplex ligation-dependent probe amplification (MLPA) was used to test a group of 21 unrelated patients with clinical features consistent with either BFNS, benign familial neonatal-infantile seizures or sporadic neonatal seizures, for exonic deletions and duplications.
RESULTS: Three deletions and one duplication mutation were identified in four familial cases and cascade testing of their available family members showed that the mutations segregated with the phenotype in each family. The junction fragment for one of the deletions was amplified by PCR and sequenced to characterise the breakpoint and verify that a deletion had occurred.
CONCLUSIONS: Submicroscopic deletions or duplications of KCNQ2 are seen in a significant proportion of BFNS families: four of nine (44%) cases previously testing negative for coding or splice site mutation by sequencing KCNQ2 and KCNQ3. MLPA is an efficient second-tier testing strategy for KCNQ2 to identify pathogenic intragenic mutations not detectable by conventional DNA sequencing methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675531      PMCID: PMC2652819          DOI: 10.1136/jmg.2007.051938

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  14 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction.

Authors:  M C Richards; S E Heron; H E Spendlove; I E Scheffer; B Grinton; S F Berkovic; J C Mulley; A Davy
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

3.  Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2.

Authors:  Xihui Zhou; Aiqun Ma; Xiaohong Liu; Chen Huang; Yanmin Zhang; Ruiming Shi; Shiwei Mao; Tao Geng; Shengbin Li
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

4.  SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum.

Authors:  Eric Herlenius; Sarah E Heron; Bronwyn E Grinton; Deborah Keay; Ingrid E Scheffer; John C Mulley; Samuel F Berkovic
Journal:  Epilepsia       Date:  2007-03-26       Impact factor: 5.864

5.  A potassium channel mutation in neonatal human epilepsy.

Authors:  C Biervert; B C Schroeder; C Kubisch; S F Berkovic; P Propping; T J Jentsch; O K Steinlein
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

6.  A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.

Authors:  N A Singh; C Charlier; D Stauffer; B R DuPont; R J Leach; R Melis; G M Ronen; I Bjerre; T Quattlebaum; J V Murphy; M L McHarg; D Gagnon; T O Rosales; A Peiffer; V E Anderson; M Leppert
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

7.  Sodium-channel defects in benign familial neonatal-infantile seizures.

Authors:  Sarah E Heron; Kathryn M Crossland; Eva Andermann; Hilary A Phillips; Allison J Hall; Andrew Bleasel; Michael Shevell; Suha Mercho; Marie-Helene Seni; Marie-Christine Guiot; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

8.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.

Authors:  Nanda A Singh; Peter Westenskow; Carole Charlier; Chris Pappas; Jonathan Leslie; Jessica Dillon; V Elving Anderson; Michael C Sanguinetti; Mark F Leppert
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  A novel SCN2A mutation in family with benign familial infantile seizures.

Authors:  Pasquale Striano; Laura Bordo; Maria Luisa Lispi; Nicola Specchio; Carlo Minetti; Federico Vigevano; Federico Zara
Journal:  Epilepsia       Date:  2006-01       Impact factor: 5.864

10.  Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy.

Authors:  Samuel F Berkovic; Sarah E Heron; Lucio Giordano; Carla Marini; Renzo Guerrini; Robert E Kaplan; Antonio Gambardella; Ortrud K Steinlein; Bronwyn E Grinton; Joanne T Dean; Laura Bordo; Bree L Hodgson; Toshiyuki Yamamoto; John C Mulley; Federico Zara; Ingrid E Scheffer
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

View more
  15 in total

Review 1.  Epilepsy and the new cytogenetics.

Authors:  John C Mulley; Heather C Mefford
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 2.  KV7 channelopathies.

Authors:  Snezana Maljevic; Thomas V Wuttke; Guiscard Seebohm; Holger Lerche
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

3.  Copy number variation plays an important role in clinical epilepsy.

Authors:  Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

4.  A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33.

Authors:  Ryan N Traylor; Damien L Bruno; Trent Burgess; Robert Wildin; Anne Spencer; Devika Ganesamoorthy; David J Amor; Matthew Hunter; Michael Caplan; Jill A Rosenfeld; Aaron Theisen; Beth S Torchia; Lisa G Shaffer; Blake C Ballif; Howard R Slater
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 5.  Nervous system KV7 disorders: breakdown of a subthreshold brake.

Authors:  Snezana Maljevic; Thomas V Wuttke; Holger Lerche
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

6.  Site-directed mutagenesis of neonatal convulsions associated KCNQ2 gene and its protein expression.

Authors:  Xi-Hui Zhou; Zhi-Yan Hui; Rui-Ming Shi; Hong-Xia Song; Wei Zhang; Li Liu
Journal:  Transl Pediatr       Date:  2012-10

Review 7.  Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models.

Authors:  Renzo Guerrini; Carla Marini; Massimo Mantegazza
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

8.  Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.

Authors:  Sarah Weckhuysen; Vanja Ivanovic; Rik Hendrickx; Rudy Van Coster; Helle Hjalgrim; Rikke S Møller; Sabine Grønborg; An-Sofie Schoonjans; Berten Ceulemans; Sinead B Heavin; Christin Eltze; Rita Horvath; Gianluca Casara; Tiziana Pisano; Lucio Giordano; Kevin Rostasy; Edda Haberlandt; Beate Albrecht; Andrea Bevot; Ira Benkel; Steffan Syrbe; Beth Sheidley; Renzo Guerrini; Annapurna Poduri; Johannes R Lemke; Simone Mandelstam; Ingrid Scheffer; Marco Angriman; Pasquale Striano; Carla Marini; Arvid Suls; Peter De Jonghe
Journal:  Neurology       Date:  2013-10-09       Impact factor: 9.910

9.  In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.

Authors:  Susan E Tomlinson; Hugh Bostock; Bronwyn Grinton; Michael G Hanna; Dimitri M Kullmann; Matthew C Kiernan; Ingrid E Scheffer; Samuel F Berkovic; David Burke
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

10.  Genetic variations and associated pathophysiology in the management of epilepsy.

Authors:  John C Mulley; Leanne M Dibbens
Journal:  Appl Clin Genet       Date:  2011-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.